Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0000950170-24-076710

Options or other derivatives

  • Chief Medical Officer acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Puhlmann Markus Chief Medical Officer 2024-06-20 Grant or award · Stock option (right to buy) +150,000 150,000 D: show line 1 in the form
Loading xslF345X05/ownership.xml…